Mediclinic shares down as Spire takeover bid fails | Fin24
  • Another VAT hike?

    Absa warns that govt may again announce an increase in value added tax in next month's Budget.

  • SA Revenue Service

    The tax agency says a unit that tackles illicit financial flows has recovered R2.6bn since April 2019.

  • State Capture Inquiry

    Former Eskom chairperson Zola Tsotsi says Tony Gupta threatened to have him removed.


Mediclinic shares down as Spire takeover bid fails

Nov 20 2017 12:38

(Mediclinic website)

Company Data


Last traded 73
Change -2
% Change -2
Cumulative volume 17910
Market cap 0

Last Updated: 01/01/0001 at 12:00. Prices are delayed by 15 minutes. Source: McGregor BFA

Related Articles

Mediclinic revenue flat in constant currency terms

Top UK hospital firm rejects Mediclinic takeover offer

Mediclinic still positive about Middle East operations

Beware: Fake Life Healthcare jobs advertised

Mediclinic merger hits competition hurdle

Mediclinic slides on concerns of slow Middle East recovery


Cape Town – Mediclinic International Plc’s [JSE:MEI] takeover bid of UK-based Spire Healthcare Group is off the table, the company announced in a shareholder notice on Monday.

“Mediclinic confirms that, following further considerations and discussions with the independent directors of Spire, it was unable to reach agreement on the terms of a transaction,” the JSE-listed private hospital group said.

Fin24 reported in October that Spire rejected a takeover proposal from Mediclinic International, its biggest shareholder, which currently owns about a third of Spire.

At the time, Mediclinic approached the company with an offer that valued its shares at 298.6 pence apiece in cash and stock, representing a 29% premium to Spire’s closing price on October 17, the day prior to the offer.

Mediclinic said on Monday that it does not intend to make an offer for Spire and is bound by the restrictions under Rule 2.8 of the City Code on Takeovers and Mergers.

“Mediclinic is disappointed that it could not reach an agreement with the independent directors of Spire, but will continue to take a disciplined approach to capital allocation to ensure investments are in the best interests of Mediclinic shareholders. Mediclinic has every intention of remaining a supportive shareholder of Spire,” it said.

It further explained that Mediclinic reserves the right to announce an offer or take any other action which would otherwise be restricted under Rule 2.8 of the City Code within the next six months following the date of this announcement.

A copy of this announcement will be available on Mediclinic’s corporate website.

Shortly before noon Mediclinic shares were trading 4.04% down on the JSE at R99.80. 

* Sign up to Fin24's top news in your inbox: SUBSCRIBE TO FIN24 NEWSLETTER

mediclinic  |  takeover


Company Snapshot

Voting Booth

How concerned are you about ransomware attacks?

Previous results · Suggest a vote